Litcius/Paper detail

Predictors of Response to Vedolizumab in Patients with Ulcerative Colitis: Results from the Greek VEDO-IBD Cohort

Giorgos Bamias, Georgios Kokkotis, Michalis Gizis, Christina Kapizioni, Konstantinos Κarmiris, Evgenia Koureta, Nikolaos Kyriakos, Georgios Leonidakis, Konstantinos Makris, Panagiotis Markopoulos, Georgios Michalopoulos, Spyridon Michopoulos, Ioannis Papaconstantinou, Dimitrios Polymeros, Spyros I. Siakavellas, Κonstantinos Τriantafyllou, Eftychia Tsironi, Emmanouela Tsoukali, Maria Tzouvala, Nikos Viazis, V. Xourafas, Eirini Zacharopoulou, Evanthia Zampeli, Konstantinos G. Zografos, George Papatheodoridis, Gerasimos Mantzaris

2021Digestive Diseases and Sciences19 citationsDOIOpen Access PDF

Topics & Concepts

VedolizumabUlcerative colitisMedicineTransplant surgeryHepatologyInternal medicineGastroenterologyCohortInflammatory bowel diseaseCohort studyColitisDiseaseInflammatory Bowel DiseaseRheumatoid Arthritis Research and TherapiesLiver Diseases and Immunity